The trick with high-yield dividend stocks is that they sound great on the surface, but they can be oh so dangerous … and the high yield could actually be the warning sign.
High dividend yields can often be a product of a severely reduced stock price, and while quick dips can happen on market sentiment, monster gaps down usually happen for a reason.
Top 10 Income Companies To Watch In Right Now: ATA Inc.(ATAI)
ATA Inc., through its subsidiaries, provides computer-based testing services in the People?s Republic of China. It offers services for the creation and delivery of computer-based tests utilizing its test delivery platform, proprietary testing technologies, and testing services; and provides logistical support services relating to test administration. The company?s computer-based testing services are used for professional licensure and certification tests in various industries, including information technology (IT) services, banking, securities, teaching, and insurance. Its e-testing platform integrates various aspects of the test delivery process for computer-based tests ranging from test form compilation to test scoring, and results analysis. ATA also provides career-oriented educational services, such as single course programs, degree major course programs, and pre-occupational training programs focusing on preparing students to pass IT and other vocational certification tests; test preparation and training programs and services to test candidates preparing to take professional certification tests in securities, futures, banking, insurance and teaching industries; online test preparation and training platform for the securities and banking industries; and test preparation software for the teaching industry. In addition, the company offers HR select employee assessment solution, an online system that utilizes its proprietary software and an inventory of test titles to help employers improve the efficiency and accuracy of their employee recruitment process. As of March 31, 2010, it had contractual relationships with 1,988 ATA authorized test centers. The company serves Chinese governmental agencies, professional associations, IT vendors, and Chinese educational institutions, as well as individual test preparation services. ATA Inc. was founded in 1999 and is based in Beijing, the People?s Republic of China.
Advisors' Opinion:- [By Jake L'Ecuyer]
Leading and Lagging Sectors
Industrials stocks gained Friday, with ATA (NASDAQ: ATAI) leading advancers. Meanwhile, gainers in the sector included Plug Power (NASDAQ: PLUG), with shares up 22 percent, and Korn/Ferry International (KFY), with shares up 12 percent. In trading on Friday, basic materials shares were relative laggards, down on the day by about 1.36 percent. - [By Jake L'Ecuyer]
Leading and Lagging Sectors
Industrials stocks gained Friday, with ATA (NASDAQ: ATAI) leading advancers. Meanwhile, gainers in the sector included Plug Power (NASDAQ: PLUG), with shares up 22 percent, and Korn/Ferry International (KFY), with shares up 12 percent. In trading on Friday, basic materials shares were relative laggards, down on the day by about 1.36 percent.
Top 10 Income Companies To Watch In Right Now: Ambit Biosciences Corp (AMBI)
Ambit Biosciences Corporation, incorporated on May 17, 2000, is a biopharmaceutical company. The Company focused on the discovery, development and commercialization of drugs to treat unmet medical needs in oncology, autoimmune and inflammatory diseases by inhibiting kinases that are important drivers for those diseases. The Company�� lead drug candidate, quizartinib, is in Phase IIb clinical development in patients with relapsed/refractory acute myeloid leukemia (AML). The Company�� second drug candidate in clinical development, AC410, is a potent, selective, orally-administered, small molecule inhibitor of Janus kinase 2 (JAK2) that has potential utility for the treatment of autoimmune and inflammatory diseases. The Company�� third program consists of two selective small molecule compounds, AC708 and AC855, which inhibit the colony-stimulating factor-1 receptor (CSF1R), a receptor tyrosine kinase.
Quizartinib
The Company�� lead drug candidate, quizartinib, is a once-daily, orally-administered, potent and selective inhibitor of FLT3, a validated target in the treatment of AML, and is in Phase IIb clinical development. The FLT3-ITD mutation acts like a power switch that causes leukemic cells, or blasts, to spread more aggressively and grow back more rapidly following chemotherapy, conferring an especially poor survival outcome. Quizartinib is designed to turn off this switch. The Company is developing a companion diagnostic test with Genoptix Medical Laboratory, a Novartis company, to identify FLT3-ITD positive patients.
AC410
The Company�� advanced drug candidate, AC410, is a potent, selective, orally-administered, small molecule inhibitor of JAK2, which has potential utility for the treatment of autoimmune and inflammatory diseases. Signaling through JAK controls the activation, proliferation and survival of various types of immune cells, and overactivation of such cells can exacerbate a range of normal inflammatory processes, resulting i! n inflammation. The Company�� initial JAK2 drug candidate, AC430, is a racemic mixture (50/50) of two enantiomers (mirror images), AC410 and AC409, and was studied in a Phase I clinical trial.
CSF1R Program
The Company is developing two potent and exquisitely selective small molecule compounds, AC708 and AC855 that both inhibit CSF1R and have potential utility in oncology, autoimmune and inflammatory diseases. Signaling through CSF1R controls the activation, proliferation and survival of macrophages, which are key mediators of immune system function and over-activation of macrophages, may result in exacerbation of certain diseases.
The Company competes with Abbvie Inc., Akinion Pharmaceuticals AB, Amgen Inc., ARIAD Pharmaceuticals, Inc., AROG Pharmaceuticals, LLC, ArQule, Inc., Astellas, AstraZeneca plc, Bayer AG, Celgene Corporation, Daiichi-Sankyo Company Limited, Galapagos NV, GlaxoSmithKline plc, Incyte Corporation, Janssen Pharmaceuticals, Inc., Johnson & Johnson, Eli Lilly and Company, Novartis, Onyx Pharmaceuticals, Inc., Pfizer, Rigel Pharmaceuticals, Inc., F. Hoffman-LaRoche Ltd, and Vertex Pharmaceuticals Incorporated.
Advisors' Opinion:- [By Wallace Witkowski]
Ambit Biosciences Corp. (AMBI) �shares fell more than 37% to $8 in moderate volume. The small-cap biotech said it will not file an accelerated approval application with the Food and Drug Administration for its leukemia drug quizartinib after the agency disagreed with the company about the use of certain study data to support the drug�� efficacy.
10 Best Food Stocks For 2015: Response Genetics Inc.(RGDX)
Response Genetics, Inc., a life sciences company, engages in the research, development, marketing, and sale of clinical diagnostic tests and pharmacogenomic tests for use in the treatment of cancer primarily in the United States, Asia, and Europe. The company develops genetic tests that measure predictive factors for tumor response in tumor tissue samples. It offers tests for non-small cell lung cancer under the ResponseDX: Lung trade name; colorectal cancer under the ResponseDX: Colon trade name; and gastric and gastroesophageal cancer under the ResponseDX: Gastric trade name. The company also develops tests for other types of cancer that identify genetic profiles of tumors that recur after surgery. Response Genetics, Inc. offers its products through its sales force to community based oncologists, hospitals, and physician offices. In addition, it provides pharmacogenomic testing services to pharmaceutical companies. The company was formerly known as Bio Type, Inc. and cha nged its name to Response Genetics, Inc. in August 2000. Response Genetics, Inc. was founded in 1999 and is headquartered in Los Angeles, California.
Advisors' Opinion:- [By Monica Gerson]
Response Genetics (NASDAQ: RGDX) slipped 9.47% to $1.34 after the company reported Q4 results. The company posted a quarterly net loss of $3.2 million, or $0.09 per share, versus a year-ago net loss of $0.5 million, or $0.01 per share.
Top 10 Income Companies To Watch In Right Now: Calamos Asset Management Inc.(CLMS)
Calamos Asset Management Inc. is a publicly owned investment manager. The firm provides investment advisory services to individuals including high net worth individuals, and institutions. It also manages accounts for family offices and private foundations. The firm manages separate client-focused equity and fixed income for its clients. It also launches and manages equity, fixed income, and balanced mutual funds for its clients. The firm invests in the public equity and fixed income markets across the globe. It also invests in alternative investments markets. The firm primarily invests in growth stocks of large-cap, mid-cap, and small-cap companies to make its investments. For fixed income, it invests in high yield bonds. The firm employs qualitative and fundamental analysis with a top-down and bottom-up stock picking approach to make its investments. It benchmarks the performance of its equity portfolios against the MSCI Indices, Russell Indices, and S&P 500 Index and its fixed income investments against the BofA Merrill Lynch Global 300 Convertible Index, BofA Merrill Lynch All U.S. Convertibles Ex-Mandatory Index, and CS High Yield Index. Calamos Asset Management Inc. was founded in 1977 and is based in Naperville, Illinois.
Advisors' Opinion:- [By GuruFocus]
Director Eric Singer sold 343,410 shares of SIGM stock on 12/20/2013 at the average price of 5.5. Eric Singer owns at least 464,499 shares after this. The price of the stock has decreased by 15.45% since.
Calamos Asset Management, Inc. (CLMS): Chairman, CEO & Global Co-CIO, 10% Owner John P Sr Calamos Bought 74,505 SharesChairman, CEO & Global Co-CIO, 10% Owner of Calamos Asset Management, Inc. (CLMS) John P Sr Calamos bought 74,505 shares during the past week at an average price of $11.99. Calamos Asset Management, Inc., is a global asset management firm that offers strategies to fulfill a range of asset allocation goals through a multi-team platform. Calamos Asset Management, Inc. has a market cap of $245.547 million; its shares were traded at around $11.99 with a P/E ratio of 20.20 and P/S ratio of 0.88. The dividend yield of Calamos Asset Management, Inc. stocks is 4.18%.
Top 10 Income Companies To Watch In Right Now: Westmoreland Coal Company(WLB)
Westmoreland Coal Company operates as an energy company in the United States. The company, through its subsidiaries, engages in the production and sale of sub-bituminous coal and lignite to electricity generating plants; and the ownership of power plants in North Carolina. It owns 5 surface coal mines in Montana, North Dakota, and Texas; and 2 coal-fired power generating units with a capacity of approximately 230 megawatts in Weldon, North Carolina. As of December 31, 2010, Westmoreland Coal Company had estimated proven and probable coal reserves of 389.9 million tons. The company was founded in 1854 and is headquartered in Englewood, Colorado.
Advisors' Opinion:- [By Jake L'Ecuyer]
Leading and Lagging Sectors
In trading on Tuesday, energy shares were relative leaders, up on the day by about 1.41 percent. Meanwhile, top gainers in the sector included Stone Energy (NYSE: SGY), up 9 percent, and Westmoreland Coal Co (NYSE: WLB), up 7.8 percent. Industrials services shares gained by just 0.02 percent in Tuesday's trading. - [By Jake L'Ecuyer]
Leading and Lagging Sectors
In trading on Tuesday, energy shares were relative leaders, up on the day by about 1.41 percent. Meanwhile, top gainers in the sector included Stone Energy (NYSE: SGY), up 9 percent, and Westmoreland Coal Co (NYSE: WLB), up 7.8 percent. Industrials services shares gained by just 0.02 percent in Tuesday's trading. - [By John Udovich]
Obama�� war on coal has claimed another victim as James River Coal Company (NASDAQ: JRCC) files for Chapter 11, but coal stocks Westmoreland Coal Company (NASDAQ: WLB), Alliance Resource Partners, L.P. (NASDAQ: ARLP) and Hallador Energy Co (NASDAQ: HNRG) have still managed to put in a decent performance for investors���despite the industry headwinds coming from the White House. Just consider this: By 2025, 300 of America�� coal plants will close due to EPA policies for a total of 44,000 megawatts of generating capacity in 33 states to be taken off line. Moreover, Democrats have been putting up roadblocks to stop coal exports���one potential industry bright spot as the US�has the largest coal repository in the world.
Top 10 Income Companies To Watch In Right Now: Ascena Retail Group Inc.(ASNA)
Ascena Retail Group, Inc. operates as a specialty retailer of apparel for women and tween girls in the United States, Puerto Rico, and Canada. The company operates its stores under the dressbarn, maurices, and Justice brand names. Its dressbarn and maurices stores offer casual and career fashion apparel and accessories; and Justice stores provide apparel, accessories, footwear, and intimates, as well as lifestyle products, such as bedroom furnishings and electronics primarily for tween girls. As of March 01, 2012, Ascena Retail Group operated approximately 2,500 stores. The company was formerly known as Dress Barn, Inc. and changed its name to Ascena Retail Group, Inc. in January 2011. Ascena Retail Group, Inc. was founded in 1962 and is based in Suffern, New York.
Advisors' Opinion:- [By Jake L'Ecuyer]
Ascena Retail Group (NASDAQ: ASNA) shares tumbled 4.29 percent to $18.06 after the company reported Q2 results. Ascena Retail expected FY14 earnings of $1.00 to 1.05 per share.
- [By Lauren Pollock]
Among the companies with shares expected to actively trade in Wednesday’s session are Mako Surgical Corp.(MAKO), Ascena Retail Group Inc.(ASNA) and Oncothyreon Inc.(ONTY)
- [By Lauren Pollock]
Ascena Retail Group Inc.'s(ASNA) fiscal first-quarter earnings rose 22% as the apparel retailer reported broad sales growth and stronger margins. Shares of Ascena, which affirmed its fiscal-year guidance, were up 4.2% at $21.75 in premarket trading as adjusted earnings and revenue beat expectations.
Top 10 Income Companies To Watch In Right Now: Ever-Glory International Group Inc.(EVK)
Ever-Glory International Group, Inc., together with its subsidiaries, engages in the manufacture, distribution, and sale of apparel for women, men, and children. Its products include coats, jackets, slacks, skirts, shirts, trousers, vests, skiwear, down jackets, knitwear, and jeans. The company offers its products to the casual wear, sportswear, and outerwear brands, as well as retailers, such as department stores, flagship stores, stores-within-a-store, and specialty stores primarily in Europe, the United States, Japan, and the People?s Republic of China. As of December 31, 2010, it operated 293 retail stores in the People?s Republic of China. The company is based in West Covina, California.
Advisors' Opinion:- [By John Udovich]
Small cap apparel stock G-III Apparel Group, Ltd (NASDAQ: GIII) has been making bullish moves lately plus the stock is up 97.1% since the start of the year, making it the third best performing apparel stock (according to stock screener Finviz)�after small cap�Ever-Glory International Group Inc (NYSEMKT: EVK) and mid cap Fifth & Pacific Companies Inc (NYSE: FNP) followed by mid cap Hanesbrands Inc (NYSE: HBI). But is the G-III Apparel Group dressed for long term success for investors?
Top 10 Income Companies To Watch In Right Now: Trovagene Inc (TROV)
TrovaGene, Inc. (TrovaGene), incorporated on April 26, 2002, is a development-stage molecular diagnostic company that focuses on the development and marketing of urine-based nucleic acid tests for patient/disease screening and monitoring. The Company's novel tests predominantly use transrenal DNA (Tr-DNA) and transrenal RNA (Tr-RNA). The Company's technology is used to all transrenal nucleic acids (Tr-NA). The Company�� urine-based test addresses market needs, such as women�� healthcare-fetal medicine-down syndrome, infectious diseases, cancer testing, transplantation, drug development and monitoring of therapeutic outcomes, ultra-sensitive analytical and detection system, technologies for the collection, shipment and storage of urine specimens, and transrenal nucleic acid extraction, and instrumentation/system platform.
On January 18, 2011, the Company entered into an asset purchase agreement pursuant to which the Company acquired a hybridoma able to produce a monoclonal antibody targeting the NPM1 biomarker. On February 8, 2011, the Company entered into a sublicense agreement with MLL Munchner Leukamielabor (MLL). In July, 2011, the Company entered into a sublicense agreement with Fairview Health Services (Fairview) for NPM1 patent rights.
In October 2011, the Company entered into a license agreement pursuant to which the Company licensed the patent rights to a specific gene mutation with respect to chronic lymphoblastic leukemia. On December 12, 2011, the Company entered into a license agreement pursuant to which the Company licensed the patent rights to hairy cell leukemia biomarkers. On February 1, 2012, the Company acquired the clinical laboratory improvement amendments (CLIA) laboratory assets of MultiGEN Diagnostics, Inc. (MultiGEN).
Advisors' Opinion:- [By Daniel Lauchheimer]
In the past few weeks, I wrote two articles about TrovaGene (TROV) -- one detailing the history of the DNA market generally and the molecular diagnostics -- and TROV's place therein -- market specifically, and the second detailing the company's internal valuation. In this article, I will value TROV on an external, relative basis. Specifically, I will compare TROV to another molecular diagnostics company, Exact Sciences (EXAS), and try to show that while the market seems to have given EXAS a fair shake, it has not done the same for TROV. I will prove this argument by looking at both companies' addressable markets, and their respective progress at bringing the products to market. However, before we take this deep dive into both companies, I will take a moment to review each of the companies' products, so we have a strong background before turning to the deeper analysis.
- [By Roberto Pedone]
TrovaGene (TROV) is a development stage molecular diagnostic company focused on the development and marketing of urine-based nucleic acid tests for patient/disease screening and monitoring. This stock closed up 6% to $10.02 in Friday's trading session.
Friday's Volume: 712,000
Three-Month Average Volume: 183,106
Volume % Change: 294%From a technical perspective, TROV ripped higher here into all-time high territory with heavy upside volume. This stock has been uptrending strong for the last month and change, with shares soaring higher from its low of $5.75 to its new all-time high of $10.20. During that move, shares of TROV have been making mostly higher lows and higher highs, which is bullish technical price action. That move has also been accompanied by bullish upside volume flows.
Traders should now look for long-biased trades in TROV as long as it's trending above its recent breakout level of $8.83, and then once it sustains a move or close above its all-time high of $10.20 with volume that hits near or above 183,106 shares. If we get that move soon, then TROV will set up to enter new all-time high territory, which is bullish technical price action. Some possible upside targets off that move are $13 to $15.
- [By David Goodboy]
Fortunately, diagnostic issues may soon be a thing of the past. Several publicly traded companies are currently making great strides in the field of medical diagnostics, and my favorite company right now in that arena is TrovaGene (Nasdaq: TROV).
Top 10 Income Companies To Watch In Right Now: Parker Drilling Company(PKD)
Parker Drilling Company, together with its subsidiaries, provides contract drilling and drilling-related services in the United States, Latin America, Africa and the Middle East (AME), the Asia Pacific, and Commonwealth of Independent States (CIS). As of December 31, 2010, its fleet consisted of 11 rigs in the CIS/AME region; 10 rigs in the Americas region, including 7 land rigs and 1 barge rig in Mexico, and 2 land rigs in Colombia; 5 land rigs in the Asia Pacific region, including 2 rigs in Indonesia, 1 rig in Papua New Guinea, and 2 rigs in New Zealand; 13 barge drilling rigs in the inland shallow waters of the U.S. Gulf of Mexico; and 1 unassigned land rig held in New Iberia, Louisiana. The company also offers premium rental tools, including drill pipe, drill collars, tubing, high- and low-pressure blowout preventers, choke manifolds, junk and cement mills, and casing scrapers for land and offshore oil and gas drilling and workover activities. In addition, it provides non-capital intensive services, such as front end engineering and design; engineering, procurement, construction, and installation; operations and maintenance; and other project management services, which include labor, maintenance, and logistics for operators who own their own drilling rigs. The company serves independent and national oil and gas companies, and integrated service providers. Parker Drilling Company was founded in 1934 and is headquartered in Houston, Texas.
Advisors' Opinion:- [By Rich Smith]
Houston-based Parker Drilling Co. (NYSE: PKD ) has a new CFO.
On Thursday, Parker announced that it has hired away offshore driller Ensco plc's vice president and treasurer, Christopher T. Weber, to become its own senior VP and Chief Financial Officer. Weber will take office on May 20.
Top 10 Income Companies To Watch In Right Now: SunCoke Energy Inc (SXC)
SunCoke Energy, Inc. (SunCoke), incorporated on December 8, 2010, is an independent producer of coke, a principal raw material in the integrated steelmaking process. The Company has United States cokemaking operations in Virginia, Indiana, Ohio and Illinois. Outside the United States, SunCoke has cokemaking operations in Vitoria, Brazil and Odisha, India. The Company�� coal mining operations, which have more than 110 million tons of proven and probable reserves, are located in Virginia and West Virginia. In January 2012, SunCoke Energy, Inc. was spun off from Sunoco, Inc.
The Company has designed, developed and built, and owned and operated five cokemaking facilities in the United States (U.S.) and designed and operate one cokemaking facility in Brazil under licensing and operating agreements on behalf of its customer. The cokemaking facility operated in Brazil has cokemaking capacity of approximately 1.7 million tons of coke per year. As of December 31, 2012, its mining area consisted of 13 active underground mines and two active surface and highwall mine in Russell and Buchanan Counties in Virginia and McDowell County, West Virginia. As of December 31, 2012, the Company�� coal mining production was 1.5 million ton.
As of December 31, 2012, the Company owned approximately 66 acres in Vansant (Buchanan County), Virginia, on which the Jewell coke making facility is located, along with an additional 2,550 acres. As of December 31, 2012, the Company owned approximately 250 acres in Russell County, Virginia owned by the HKCC Companies. As of December 31, 2012, the Company owned approximately 400 acres in Franklin Furnace (Scioto County), Ohio. As of December 31, 2012, the Company owned approximately 41 acres in Granite City (Madison County), Illinois, adjacent to the U.S. Steel Granite City Works facility. As of December 31, 2012, the Company owned approximately 250 acres in Middletown (Butler County), Ohio near AK Steel�� Middletown Works facility. The Company leas! ed approximately 88 acres of land located in East Chicago (Lake County), Indiana. As of December 31, 2012, the Company leased approximately 22 acres of land located in Buchanan County, Virginia The Company owns and operates coal mining operations in Virginia and West Virginia that sold approximately 1.3 million tons of metallurgical coal (including internal sales to its cokemaking operations) and 0.2 million tons of thermal coal in 2012. During the year ended December 31, 2012, 69% of the coal the Company sold was used at its Jewell cokemaking facility and 8% was used at its other domestic cokemaking facilities. In addition, through its Jewell coal affiliates and the HKCC Companies, the Company lease small parcels of land, mineral rights and coal mining rights for approximately 127 thousand acres of land in Buchanan and Russell Counties, Virginia and McDowell County, West Virginia.
Advisors' Opinion:- [By Johanna Bennett]
In a note published Friday, Goldman analysts Neil Mehta and Vinit Joshi issued a mix of outlooks for the batter coal sector, among them Buy ratings on CONSOL Energy (CNX) and SunCoke Energy (SXC) and a Sell on Arch Coal (ACI).
- [By Jon C. Ogg]
SunCoke Energy Inc. (NYSE: SXC) was started with a Buy rating and given a $22 price target (versus a $16.77 close). SunCoke mines and produces coke and offers metallurgical and thermal coal for steel making.
No comments:
Post a Comment